Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Predicting Readmission Risk with Institution Specific Prediction Models
24
Zitationen
6
Autoren
2013
Jahr
Abstract
The ability to predict patient readmission risk is extremely valuable for hospitals, especially under the Hospital Readmission Reduction Program (HRRP) of the Center for Medicare and Medicaid Services (CMS) which went into effect starting October 1, 2012. There is a plethora of work in the literature that deals with developing readmission risk prediction models, but most of them do not have sufficient prediction accuracy to be deployed in a clinical setting, partly because different hospitals may have different characteristics in their patient populations. In this work we experimented with a generic framework for institution-specific readmission risk prediction, which takes patient data from a single institution and produces a statistical risk prediction model optimized for that particular institution and optionally condition specific. This provides great flexibility in model building, and is also able to provide institution-specific insights in its readmitted patient population. We showcase some initial results at three institutions for Heart Failure (HF), Acute Myocardial Infarction (AMI) and Pneumonia (PN) patients. The developed models yield better prediction accuracy than the ones present in the literature.
Ähnliche Arbeiten
Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
2021 · 19.543 Zit.
2013 ACCF/AHA Guideline for the Management of Heart Failure
2013 · 12.613 Zit.
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
2021 · 12.589 Zit.
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 · 11.735 Zit.
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
2002 · 11.655 Zit.